KATNA1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.647700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.024100E-02
Normal-vs-Stage2
9.210000E-02
Normal-vs-Stage3
6.074200E-02
Normal-vs-Stage4
8.428600E-01
Stage1-vs-Stage2
5.246400E-01
Stage1-vs-Stage3
6.195800E-01
Stage1-vs-Stage4
8.102000E-02
Stage2-vs-Stage3
2.620800E-01
Stage2-vs-Stage4
2.387600E-02
Stage3-vs-Stage4
9.286400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.075580E-01
Normal-vs-AfricanAmerican
7.847800E-02
Normal-vs-Asian
2.129600E-02
Caucasian-vs-AfricanAmerican
6.394800E-01
Caucasian-vs-Asian
3.447200E-01
AfricanAmerican-vs-Asian
1.787820E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.260100E-02
Normal-vs-Female
1.269830E-01
Male-vs-Female
5.640000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.311400E-01
Normal-vs-Age(41-60Yrs)
1.955390E-01
Normal-vs-Age(61-80Yrs)
6.710400E-02
Normal-vs-Age(81-100Yrs)
8.224000E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.737600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.862000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.136000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.182500E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.519400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.712600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.427790E-01
Normal-vs-Daily Drinker
2.713900E-02
Normal-vs-Weekly Drinker
3.413400E-01
Normal-vs-Occasional Drinker
1.198750E-01
Normal-vs-Social Drinker
1.252160E-01
Non Drinker-vs-Daily Drinker
3.909600E-01
Non Drinker-vs-Weekly Drinker
3.311800E-01
Non Drinker-vs-Occasional Drinker
5.362400E-01
Non Drinker-vs-Social Drinker
7.768000E-01
Daily Drinker-vs-Weekly Drinker
7.512000E-02
Daily Drinker-vs-Occasional Drinker
1.132210E-01
Daily Drinker-vs-Social Drinker
2.568400E-01
Weekly Drinker-vs-Occasional Drinker
6.280800E-01
Weekly Drinker-vs-Social Drinker
4.929400E-01
Occasional Drinker-vs-Social Drinker
7.578200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.396800E-01
Normal-vs-Grade 2
8.050800E-01
Normal-vs-Grade 3
7.830600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.051600E-02
Grade 1-vs-Grade 3
1.916110E-02
Grade 1-vs-Grade 4
9.396800E-01
Grade 2-vs-Grade 3
6.293600E-01
Grade 2-vs-Grade 4
8.050800E-01
Grade 3-vs-Grade 4
7.830600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.119430E-01
Normal-vs-NonDiabetic
5.756100E-02
Diabetic-vs-NonDiabetic
9.148800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.255240E-01
Normal-vs-NoPancreatitis
7.029500E-02
Pancreatitis-vs-NoPancreatitis
5.580600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.297050E-01
Normal-vs-N1
9.804000E-02
N0-vs-N1
6.855400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.794500E-02
Normal-vs-TP53-NonMutant
1.122430E-01
TP53-Mutant-vs-TP53-NonMutant
6.186000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
